Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized contractual terms, and enhanced supply security. These improvements will ...

Element Biosciences created a high-throughput benchtop device that can deliver a whole genome for $100 – half the price of ...

The human genome is made up of 3 billion letters of DNA (A, T, C and G). Whole genome sequencing is a technique that is used ...

Monib Zirvi Ph.D. ’96 M.D. ’00 on Jan. 23 filed a petition asking the high court to review his malpractice claim alleging that Akin Gump, a prominent law firm who represented Cornell in litigation ...

The San Diego Zoo Wildlife Alliance announced this month it had entered into a partnership with gene-sequencing giant Illumina to use advanced DNA technology to study thousands of cryopreserved ...

Illumina Inc. (Nasdaq: ILMN), a genomics and molecular diagnostics company headquartered in San Diego, closed in late January on its acquisition of Boulder-based biotech firm SomaLogic Inc.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Despite currency headwinds and margin challenges, Devyser Diagnostics AB (FRA:OL0) achieves significant revenue growth and strategic market positioning.

Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease ...

"The fourth quarter confirmed the positive earnings trend that we have seen throughout the year. Operating profit amounted to SEK 18.0 million (-3.7) for the quarter and to SEK 10.1 million (-62.3) fo ...

Illumina’s fourth quarter was marked by strong performance in its clinical consumables business, with management citing 20% ...